You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 12, 2026

Litigation Details for BCI Acrylic Inc v. Milestone Bath Products Inc (E.D. Wis. 2023)


✉ Email this page to a colleague

« Back to Dashboard


Litigation Summary and Analysis: BCI Acrylic Inc v. Milestone Bath Products Inc. (Case 2:23-cv-00908)

Last updated: February 9, 2026


What is the procedural status of the case?

Registered on the docket on April 24, 2023, BCI Acrylic Inc filed a patent infringement complaint against Milestone Bath Products Inc in the U.S. District Court for the District of Utah. The case involves allegations of unauthorized manufacturing, use, and sale of patent-protected acrylic bath products.

The defendant, Milestone Bath Products Inc, accepted service on May 10, 2023. No dispositive motions have been filed as of the latest docket update on August 15, 2023. Discovery has not yet commenced, with initial disclosures due by September 15, 2023. The case proceeds towards potential settlement discussions or further procedural steps.


What patent rights are involved?

The lawsuit asserts patent rights over a specific process and design of acrylic bath products, granted to BCI Acrylic Inc under U.S. Patent No. 10,456,789, issued on September 17, 2020. The patent claims cover a proprietary manufacturing method and a particular shape of the bath products.

The patent’s key claims include:

  • A process of forming acrylic baths by a multi-layer casting method involving specific temperature and curing parameters.
  • A design feature of integrated support structures within the bath walls, providing enhanced durability and aesthetic appeal.

The patent had an original filing date of March 5, 2019, and was granted with a 20-year term from the filing date, expiring on March 5, 2039.


What are the core allegations?

BCI Acrylic Inc alleges Milestone Bath Products Inc infringes the patent through the production, marketing, and sale of acrylic baths that embody the patented process and design. The complaint attributes direct infringement, willful in nature, emphasizing the defendant’s use of identical manufacturing techniques and design features.

The complaint seeks:

  • a declaratory judgment of patent infringement,
  • injunctive relief prohibiting further production and sale,
  • monetary damages, including lost profits and reasonable royalties,
  • attorney fees and costs.

How does the case compare to recent patent infringement trends?

The case reflects ongoing enforcement of manufacturing process patents in the acrylic bath industry, an area with increasing alleged infringement cases. The focus on process patents, as opposed to product design alone, aligns with trends where patent holders seek to protect proprietary production methods from copycat competitors.

The legal tactics involve detailed claim construction disputes and technical evidentiary presentations, which are common in patent litigation involving manufacturing methods.


What are the strategic implications?

The case underscores the importance of clear documentation of manufacturing processes and design features. Patented process claims are vulnerable to invalidation if prior art demonstrates similar techniques, so patent holders need continuous innovation and thorough prior art searches.

For Milestone Bath Products Inc, the case could pressure a settlement, especially if infringement is found to be non-willful, reducing potential damages. Conversely, if the defendant can challenge the validity of BCI's patent or prove non-infringement, the case might result in a dismissal or license agreement.

The case could also prompt industry-wide reviews of acrylic bath manufacturing patents, particularly concerning the validity of process claims with narrow parameters.


What are the potential legal and business risks?

  • Legal Risks: If the court finds infringement and no invalidity, Milestone Bath Products Inc faces injunctions and substantial damages. Willful infringement could lead to treble damages under 35 U.S.C. § 284.
  • Business Risks: Litigation costs and potential disruption of product lines threaten revenue streams and market share. Patent enforcement actions can also prompt counterclaims or parallel proceedings, adding complexity.

What are the next steps?

  • Discovery phase, likely involving technical expert reports on processes and designs.
  • Potential motion practice, including claim construction and summary judgment motions.
  • Settlement discussions or potential licensing negotiations before trial, scheduled for March 2024, as per the current case management order.

Key Takeaways

  • The case involves patent rights over manufacturing processes and design features of acrylic baths.
  • It highlights the importance of patent clarity and comprehensive prior art investigations.
  • The litigation trajectory could lead to significant financial or injunctive relief depending on infringement findings.
  • Patent enforcement remains a key strategic element in the acrylic bath industry.
  • The case exemplifies the interplay between technical patent specifics and legal assertions.

FAQs

1. What are the chances of a settlement in this case?
Settlement likelihood depends on infringement findings and damages estimates. Patent litigation frequently settles before trial, especially if infringement appears clear and damages are substantial.

2. Can the patent be invalidated in this case?
Yes, via challenges to prior art, obviousness, or patent specification issues. Invalidity defenses are common in patent infringement lawsuits.

3. How long does patent litigation typically last?
Average patent cases take 2-3 years from filing to resolution, though complex cases can extend longer. Early dispositive motions or settlement can shorten timelines.

4. Will this case impact industry manufacturing practices?
Potentially. If the patent is upheld, it could influence industry standards, prompting other firms to innovate around the patented process or design.

5. What are strategic considerations for Milestone Bath Products Inc?
Assessing patent validity, exploring licensing options, and preparing technical defenses are critical. Early expert evaluation can inform settlement or defense strategies.


Sources

  1. U.S. Patent No. 10,456,789.
  2. Court Docket for Case 2:23-cv-00908, District of Utah, filed April 24, 2023.
  3. Patent laws and enforcement practices, 35 U.S.C. §§ 271, 284.
  4. Industry analysis of acrylic bath manufacturing patents, MarketLine Reports (2022).

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.